<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04894292</url>
  </required_header>
  <id_info>
    <org_study_id>TepecikTRH-001</org_study_id>
    <nct_id>NCT04894292</nct_id>
  </id_info>
  <brief_title>The Effect of Adenomoyosis on Pregnancy Outcomes</brief_title>
  <official_title>Adverse Obstetrical Outcomes for Women With Adenomyosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tepecik Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tepecik Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adenomyosis can be defined as the settling of endometrial gland cells in the myometrium and&#xD;
      deformity in the uterus and the prevalence of adenomyosis is according to the patient&#xD;
      population and countries around 20%. There are recent publications reporting that this rate&#xD;
      increases up to 50% in women dealing with infertility. In adenomyosis, where uterine&#xD;
      morphology is affected, it is not thought that the uterus, which is expected to provide many&#xD;
      morphological adaptations during pregnancy, will not be affected. Therefore, in this&#xD;
      prospective study, it was planned to investigate the effects of adenomyosis during pregnancy.&#xD;
&#xD;
      For this study the presence of adenomyosis will be questioned by using ultrasonographic&#xD;
      morphological uterine limitation (MUSA) in women who apply to the outpatient clinic with&#xD;
      suspicion of pregnancy and undergo transvaginal ultrasonography for the diagnosis of&#xD;
      pregnancy before sixth gestational week.&#xD;
&#xD;
      Patients will be divided into two groups according to the presence of adenomyosis and&#xD;
      pregnancy complications such as preterm labor, premature rupture of membranes, cesarean&#xD;
      section rates, preeclampsia, fetal malpresentation and preeclampsia will be compared between&#xD;
      the groups.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Months</target_duration>
  <primary_outcome>
    <measure>Pregnancy complication</measure>
    <time_frame>15 month</time_frame>
    <description>Preterm labour</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy complication</measure>
    <time_frame>16 month</time_frame>
    <description>placental anomalies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy complication</measure>
    <time_frame>17 month</time_frame>
    <description>preeclampsia, eclampsia</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Adenomyosis</condition>
  <condition>Pregnancy Complications</condition>
  <arm_group>
    <arm_group_label>Adenomyosis Group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-adenomyosis Group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non intervention</intervention_name>
    <description>During the study there is no extra intervention planned for the participants.</description>
    <arm_group_label>Adenomyosis Group</arm_group_label>
    <arm_group_label>Non-adenomyosis Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women diagnosed by TV usg before the 6th gestational week will be divided into two&#xD;
        according to the MUSA classification, and those with adenomyosis who are not in the study&#xD;
        group will be evaluated as the control group.&#xD;
&#xD;
        All the participants should be at between 18-35 age years old and all perinatal visits and&#xD;
        deliveries should be at Tepecik Obstetric Clinic.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18-35 years&#xD;
&#xD;
          -  Being diagnosed before the 6th gestational week&#xD;
&#xD;
          -  Having all pregnancy follow-ups and deliveries in our hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous uterine surgery&#xD;
&#xD;
          -  Multiple pregnancies&#xD;
&#xD;
          -  Pregnant women with uterine malformations&#xD;
&#xD;
          -  Pregnant women with fetal anomalies&#xD;
&#xD;
          -  Those who got pregnant using assisted reproductive technique&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahkam Göksel Kanmaz, Assoc. Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Tepecik Education and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Abdurrahman Hamdi İnan, Assoc. Prof.</last_name>
    <phone>(0232) 373 89 21</phone>
    <email>ahamdiinan@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tepecik Education and Research Hospital</name>
      <address>
        <city>İzmir</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Göksel Kanmaz, Assoc. Prof.</last_name>
      <phone>+905308205483</phone>
      <email>drgokselkanmaz@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Harada T, Taniguchi F, Amano H, Kurozawa Y, Ideno Y, Hayashi K, Harada T; Japan Environment and Children's Study Group. Adverse obstetrical outcomes for women with endometriosis and adenomyosis: A large cohort of the Japan Environment and Children's Study. PLoS One. 2019 Aug 2;14(8):e0220256. doi: 10.1371/journal.pone.0220256. eCollection 2019.</citation>
    <PMID>31374085</PMID>
  </reference>
  <reference>
    <citation>Horton J, Sterrenburg M, Lane S, Maheshwari A, Li TC, Cheong Y. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis. Hum Reprod Update. 2019 Sep 11;25(5):592-632. doi: 10.1093/humupd/dmz012.</citation>
    <PMID>31318420</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 16, 2021</study_first_submitted>
  <study_first_submitted_qc>May 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2021</study_first_posted>
  <last_update_submitted>May 23, 2021</last_update_submitted>
  <last_update_submitted_qc>May 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tepecik Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Ahkam Göksel Kanmaz</investigator_full_name>
    <investigator_title>Assoc. Prof</investigator_title>
  </responsible_party>
  <keyword>adenomyosis</keyword>
  <keyword>pregnancy complications</keyword>
  <keyword>MUSA classification</keyword>
  <keyword>ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregnancy Complications</mesh_term>
    <mesh_term>Adenomyosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

